FUJIFILM Diosynth Biotechnologies U.S.A., Inc., a prominent player in the biopharmaceutical industry, is headquartered in Grand Island, New York, with significant operations across the United States and Europe. Founded in 2012, the company has rapidly established itself as a leader in biomanufacturing, specialising in the development and production of biologics, including monoclonal antibodies and recombinant proteins. With a commitment to innovation, FUJIFILM Diosynth offers unique services such as cell line development, process development, and large-scale manufacturing, utilising cutting-edge technologies to ensure high-quality outputs. The company has achieved notable milestones, including partnerships with major pharmaceutical firms, solidifying its market position as a trusted contract development and manufacturing organisation (CDMO). Through its dedication to excellence, FUJIFILM Diosynth continues to advance the biopharmaceutical landscape, supporting the delivery of life-saving therapies worldwide.
We don't have data for FUJIFILM Diosynth Biotechnologies U.S.A., Inc., but we can show you information about their parent organization instead.
View parent company